Bio-Rad Reports Q4 Revenues Down 1 Percent | GenomeWeb

NEW YORK (GenomeWeb) — Bio-Rad Laboratories reported after the close of the market today an approximately 1 percent decrease in fourth quarter revenues.

The Hercules, Calif.-based company reported $598.2 million in revenues for the three months ended Dec. 31, 2014, down from $602.6 million a year ago, but surpassing the average analysts' estimate of $593.4 million.

On a currency-neutral basis, quarterly sales grew about 5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.